Evidence map›Paper›PMID 30244358›Full record

ArticleCEN case reports2019

An autopsy case of TAFRO syndrome with membranoproliferative glomerulonephritis-like lesions.

Keiko Hashimoto, Takashi Sano, Yukari Honma, Maoko Ida, Hiroshi Tominaga, Aya Sawada, Tetsuya Abe, Haruka Takahashi, Yoshitaka Shimada, Takanori Masaki and 7 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in CEN case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Keiko HashimotoDepartment of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.
Takashi SanoDepartment of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan. taksano@med.kitasato-u.ac.jp.
Yukari HonmaDepartment of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.
Maoko IdaDepartment of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.
Hiroshi TominagaDepartment of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.
Aya SawadaDepartment of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.
Tetsuya AbeDepartment of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.
Haruka TakahashiDepartment of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.
Yoshitaka ShimadaDepartment of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.
Takanori MasakiDepartment of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.
Mariko KamataDepartment of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.
Shokichi NaitoDepartment of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.
Togo AoyamaDepartment of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.
Yasuo TakeuchiDepartment of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.
Masashi AkiyaDepartment of Pathology, Kitasato University School of Medicine, Sagamihara, Japan.
Madoka InukaiDepartment of Pathology, Kitasato University School of Medicine, Sagamihara, Japan.
Norihiro NakataDepartment of Pathology, Kitasato University School of Medicine, Sagamihara, Japan.
Kitasato University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TAFRO syndrome (thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly) is an atypical manifestation of multicentric Castleman's disease. Although overproduction of interleukin-6, vascular endothelial growth factor, and other cytokines may partially explain the pathophysiology of this rare syndrome, the precise mechanisms underlying the renal dysfunction associated with the condition remain unclear. Here, we describe a case of a 69-year-old male with TAFRO syndrome. He was treated with immunosuppressive agents and his renal function improved. Tapering of immunosuppressive agents resulted in a deterioration of renal function and an elevation of C-reactive protein. After 20 months of treatment, the patient died from tuberculous peritonitis and gastrointestinal bleeding. An autopsy revealed miliary tuberculosis, mediastinal lymphadenopathy, and gastric ulcers. Renal histopathology showed a membranoproliferative glomerulonephritis-like appearance. Almost all glomeruli showed lobular formations with mesangial proliferation and duplication of glomerular capillary walls on light microscopy. Immunofluorescence showed deposition of C1q and IgM along the glomerular capillary walls. Electron microscopy showed mesangial expansion and widening of the subendothelial space with a large number of electron-dense deposits. The glomerular lesions might be characteristic of TAFRO syndrome, and were regarded as the main cause of the patient's renal dysfunction.

Indexed as

AgedAutopsyCastleman DiseaseFatal OutcomeGlomerulonephritis, MembranoproliferativeHumansKidney GlomerulusMaleHypercytokinemiaMembranoproliferative glomerulonephritis-like lesionsRenal dysfunctionTAFRO syndrome

Identifiers

PMID30244358
PMCPMC6361076
OpenAlexW2893800912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.